Literature DB >> 11687479

Correlation of CD4(+) T-Cell counts estimated by an immunocapture technique (Capcellia) with viral loads in human immunodeficiency virus-seropositive individuals.

R Kannangai1, S Ramalingam, M V Jesudason, T S Vijayakumar, O C Abraham, A Zachariah, G Sridharan.   

Abstract

As antiretroviral therapy becomes more affordable, valid, reliable, and inexpensive laboratory tests are also needed to monitor the progression of disease in people with human immunodeficiency virus (HIV) infection. The CD4(+) T-cell counts estimated by Capcellia, an immunocapture method, and flow cytometry were compared and were correlated with HIV type 1 (HIV-1) load. There was a significant negative correlation between the HIV-1 load and CD4(+) T-cell counts estimated by flow cytometry (r = -0.63, P = <0.001) as well as between the HIV-1 load and CD4(+) T-cell counts estimated by Capcellia (r = -0.61, P = <0.001). Capcellia is a cost-effective, user-friendly assay that correlated well with HIV-1 load determinations for individuals both with and without treatment.

Entities:  

Mesh:

Year:  2001        PMID: 11687479      PMCID: PMC96265          DOI: 10.1128/CDLI.8.6.1286-1288.2001

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  9 in total

1.  Human immunodeficiency virus type 1 p24 concentration measured by boosted ELISA of heat-denatured plasma correlates with decline in CD4 cells, progression to AIDS, and survival: comparison with viral RNA measurement.

Authors:  B Ledergerber; M Flepp; J Böni; Z Tomasik; R W Cone; R Lüthy; J Schüpbach
Journal:  J Infect Dis       Date:  2000-04-04       Impact factor: 5.226

2.  Comparative assessment of five alternative methods for CD4+ T-lymphocyte enumeration for implementation in developing countries.

Authors:  J M Didier; M D Kazatchkine; C Demouchy; C Moat; S Diagbouga; C Sepulveda; A M Di Lonardo; L Weiss
Journal:  J Acquir Immune Defic Syndr       Date:  2001-02-01       Impact factor: 3.731

3.  Whole blood capcellia CD4/CD8 immunoassay for enumeration of CD4+ and CD8+ peripheral T lymphocytes.

Authors:  D Carrière; J P Vendrell; C Fontaine; A Jansen; J Reynes; I Pagès; C Holzmann; M Laprade; B Pau
Journal:  Clin Chem       Date:  1999-01       Impact factor: 8.327

4.  Viral load in asymptomatic patients with CD4+ lymphocyte counts above 500 x 10(6)/l.

Authors:  F García; C Vidal; J M Gatell; J M Miró; A Soriano; T Pumarola
Journal:  AIDS       Date:  1997-01       Impact factor: 4.177

5.  1997 revised guidelines for performing CD4+ T-cell determinations in persons infected with human immunodeficiency virus (HIV). Centers for Disease Control and Prevention.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1997-01-10

6.  Evaluation of a quantitative determination of CD4 and CD8 molecules as an alternative to CD4+ and CD8+ T lymphocyte counts in Africans.

Authors:  S Diagbouga; G Durand; P T Sanou; H Dahourou; E Ledru
Journal:  Trop Med Int Health       Date:  1999-02       Impact factor: 2.622

7.  Quantitative determination of CD4/CD8 molecules by a cell marker ELISA.

Authors:  L Franke; E Nugel; W D Döcke; T Porstmann
Journal:  Clin Chem       Date:  1994-01       Impact factor: 8.327

8.  Peripheral CD4+/CD8+ T-lymphocyte counts estimated by an immunocapture method in the normal healthy south Indian adults and HIV seropositive individuals.

Authors:  R Kannangai; K J Prakash; S Ramalingam; O C Abraham; K P Mathews; M V Jesudason; G Sridharan
Journal:  J Clin Virol       Date:  2000-08       Impact factor: 3.168

9.  Prognostic significance of plasma markers of immune activation, HIV viral load and CD4 T-cell measurements.

Authors:  J L Fahey; J M Taylor; B Manna; P Nishanian; N Aziz; J V Giorgi; R Detels
Journal:  AIDS       Date:  1998-09-10       Impact factor: 4.177

  9 in total
  5 in total

1.  Usefulness of alternate prognostic serum and plasma markers for antiretroviral therapy for human immunodeficiency virus type 1 infection.

Authors:  R Kannangai; A J Kandathil; D L Ebenezer; E Mathai; A J Prakash; O C Abraham; T D Sudarsanam; S A Pulimood; R Selvakumar; V Job; G Sridharan
Journal:  Clin Vaccine Immunol       Date:  2007-11-14

Review 2.  Current practices in laboratory monitoring of HIV infection.

Authors:  Madhu Vajpayee; Teena Mohan
Journal:  Indian J Med Res       Date:  2011-12       Impact factor: 2.375

3.  CD4 measurements in patients with HIV: are they feasible for poor settings?

Authors:  Zvi Bentwich
Journal:  PLoS Med       Date:  2005-07-19       Impact factor: 11.069

4.  A microchip CD4 counting method for HIV monitoring in resource-poor settings.

Authors:  William R Rodriguez; Nicolaos Christodoulides; Pierre N Floriano; Susan Graham; Sanghamitra Mohanty; Meredith Dixon; Mina Hsiang; Trevor Peter; Shabnam Zavahir; Ibou Thior; Dwight Romanovicz; Bruce Bernard; Adrian P Goodey; Bruce D Walker; John T McDevitt
Journal:  PLoS Med       Date:  2005-07-19       Impact factor: 11.069

5.  HLA Class II Antigens and Their Interactive Effect on Perinatal Mother-To-Child HIV-1 Transmission.

Authors:  Ma Luo; Joanne Embree; Suzie Ramdahin; Thomas Bielawny; Tyler Laycock; Jeffrey Tuff; Darren Haber; Mariel Plummer; Francis A Plummer
Journal:  PLoS One       Date:  2015-05-06       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.